KDM5c Promotes Colon Cancer Cell Proliferation Through the FBXW7-c-Jun Regulatory Axis

Haishan Lin1, Nina Ma1, Lei Zhao1

  • 1Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Frontiers in Oncology
|October 12, 2020
PubMed

Insights

Overexpression of KDM5c in colon cancer promotes cell proliferation by downregulating FBXW7, leading to increased c-Jun protein accumulation. This KDM5c-FBXW7-c-Jun axis impacts patient survival and suggests therapeutic targets.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Biology

Background:

  • KDM5c is a histone demethylase involved in transcriptional repression.
  • C-Jun, a proto-oncogene, promotes cell proliferation and is degraded via the ubiquitin-proteasome pathway mediated by FBXW7.
  • FBXW7 acts as an E3 ubiquitin ligase for c-Jun and exhibits anti-cancer properties in colon cancer.

Purpose of the Study:

  • To investigate the role of KDM5c in colon cancer cell proliferation.
  • To elucidate the molecular mechanism by which KDM5c affects c-Jun protein levels and FBXW7 expression.
  • To analyze the clinical relevance of KDM5c expression in colon cancer patients.

Main Methods:

  • Overexpression of KDM5c in human colon cancer cells.
  • Analysis of FBXW7 and c-Jun mRNA and protein levels.
  • Assessment of c-Jun ubiquitination and degradation.
  • Chromatin immunoprecipitation (ChIP) assays to examine histone modifications (H3K4me3) and DNA methylation.
  • TCGA database analysis for KDM5c expression and correlation with patient survival and gene methylation.

Main Results:

  • KDM5c overexpression led to increased c-Jun protein accumulation and enhanced colon cancer cell proliferation.
  • FBXW7 transcription was attenuated by KDM5c overexpression, resulting in decreased c-Jun ubiquitination and degradation.
  • KDM5c-mediated downregulation of FBXW7 involved H3K4me3 demethylation and subsequent DNA methylation at the FBXW7 gene locus.
  • High KDM5c expression in colon cancer tissues correlated with poor patient survival and increased FBXW7 gene methylation.

Conclusions:

  • KDM5c promotes colon cancer cell proliferation by inhibiting the FBXW7-mediated degradation of c-Jun.
  • The KDM5c-FBXW7-c-Jun axis represents a critical regulatory pathway in colon cancer.
  • KDM5c may serve as a prognostic biomarker and a potential therapeutic target in colon cancer.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K